The shift in commercial teams has been happening for some time. This is not new news. I have felt it many times over, like many of us who have worked in the industry for years.
A phase 1/2 trial in AL amyloidosis saw 100% of patients obtaining at least a very good partial response with 90% obtaining a complete response.
As AI chat interfaces become the first point of interaction for HCP queries, a new kind of inventory is emerging.
Nordic Global is helping NHS organisations transform patient access through digital transformation.
Purespring CEO Haseeb Ahmad discusses transforming the treatment of kidney disease, an area of enormous unmet need, and the company's gene therapy.
Editor's Picks
